XTLB — XTL BIOPHARMACEUTICALS LTD ADR (Healthcare >> Biotechnology)
XTLB FAQ
What is XTLB's ROE?
XTL BIOPHARMACEUTICALS LTD ADR reports a Return on Equity (ROE) of -32.51%.
What is XTLB's dividend yield?
XTL BIOPHARMACEUTICALS LTD ADR offers a dividend yield of 0.00%.
What is XTLB's Deepscope Quality Score?
Deepscope rates XTLB's overall financial quality at 15 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy XTLB?
Deepscope's AI Timing Score for XTLB is 2 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does XTLB belong to?
XTL BIOPHARMACEUTICALS LTD ADR is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 2.06
Price
-0.17
(-7.62%)
Day Change
|
|
|---|
XTLB Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 15) và Thời điểm mua ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Không tốt , ...
| Yếu tố Chất lượng |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 87 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 2.06 |
| PBV / Sector |
0.88 / 4.63
GREAT
|
| Earning Per Share | -0.76 |
| PE / Sector |
N/A / 17.43
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
0.07 M
GREAT
|
| Average 1W Daily Value |
0.03 M
GREAT
|
| Yếu tố Kỹ thuật |
|
28% |
| Sức khỏe tài chính |
|
50% |
| Khả năng kiếm lợi nhuận |
|
43% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-06 09:09:20 |
| Symbol | XTLB |
| Name | XTL BIOPHARMACEUTICALS LTD ADR |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 2.37 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 4.80 / 8,857.28 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 26 Ben-Gurion St., Ramat Gan, Israel, 5112001
Phone: 972 3 611 6600
Website: https://www.xtlbio.com
Sector: Healthcare >> Biotechnology
Description: XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. Its lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. The company has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google